2m 2m 2m 2m 2m 2m 2m
Earth Life Scien (CLTS)
OTC
$0.000001$0.00 (0.00%)
Price as of Apr 24, 2026- $999.00Market Cap
- 0.00%1-Year Change
- N/AIndustry
Earth Life Scien (CLTS)
$0.000001$0.00 (0.00%)
Annual
Quarterly
12/31/2021 | 12/31/2020 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 23,421 -28.21% | 32,624 N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | |
Total Operating Expenses | 23,421 -28.21% | 32,624 N/A | |
Operating Profit | -1.6M -13.30% | -1.8M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -21,530 N/A | N/A N/A | |
Interest Income and Expense and Net | -21,530 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 21,530 N/A | N/A N/A | |
Income before Taxes | -1.6M -13.30% | -1.8M N/A | |
Income Taxes | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -1.6M -13.30% | -1.8M N/A | |
Net Income from Continuing Operations Applicable to Common | -1.6M -13.30% | -1.8M N/A | |
Basic EPS and Net Income | N/A N/A | 0.00 N/A | |
Diluted EPS and Net Income | N/A N/A | 0.00 N/A | |
Basic Weighted Average Shares | 494.6M +12.81% | 438.5M N/A | |
Diluted Weighted Average Shares | N/A N/A | 438.5M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | N/A N/A | N/A N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 0 N/A | 0 N/A | |
Total Current Assets | 600 -99.66% | 176,000 N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | |
Total Assets | 4.4M +2,415.11% | 176,000 N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 49,018 +67.48% | 29,268 N/A | |
Total Current Liabilities | 127,673 -66.22% | 377,908 N/A | |
Total Long-Term Debt | 245,135 -17.63% | 297,603 N/A | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | |
Total Liabilities | 372,808 -1.35% | 377,908 N/A | |
Retained Earnings | -18.7M +9.25% | -17.1M N/A | |
Total Stockholders Equity | 4.1M +2,107.74% | -201,908 N/A | |
Total Shares Outstanding | 960.5M +106.63% | 464.8M N/A | |
Cash Flow | |||
Cash from Operating Activities | -15,868 -65.04% | -45,383 N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 15,868 -65.04% | 45,383 N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | -68.85% -96.68% | -2,076.85% N/A | |
Return on Equity | -82.27% -112.15% | 677.28% N/A | |
Revenue Growth | N/A N/A | N/A N/A | |
Current Ratio | 0.005 -98.99% | 0.47 N/A | |
Cash Ratio | N/A N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.07 +104.48% | -1.62 N/A | |
Debt-to-Assets Ratio | 0.07 -96.42% | 1.86 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow